A pilot feasibility study to assess a new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
A new study shows that omitting aspirin from an anti-clotting regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots.
A minimally invasive procedure for fixing diseased aortic valves is just as safe and durable as traditional surgery after five years, a new study reports.
Researchers are collaborating with the NBA to create a new standard in the detection and reduction of cardiac risk among professional basketball athletes.
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a new study from Columbia researchers.
A new study has revealed that cholesterol-lowering statins may help reverse the mechanisms that increase the risk of heart disease in people with sleep apnea.
P&S researcher Wendy Chung and colleagues find genetic mutations that explain why many children with congenital heart disease also have neurodevelopmental disorders.
The NIH has granted $8.56 million for a first of its kind clinical trial examining cardiovascular disease in patients with rheumatoid arthritis. One of the principal investigators is Columbia's Joan Bathon.
Columbia researcher Jon Giles has published research showing a link between atherosclerosis and depressive symptoms, stress, anxiety, anger, and lack of social support in patients with rheumatoid arthritis.
Columbia research shows that expanding treatment of high blood pressure with cost-effective medication could prevent 1 million heart attacks and strokes in China.